Results 121 to 130 of about 110,931 (189)

Patient Perspectives on Systemic Bevacizumab Treatment for Recurrent Respiratory Papillomatosis. [PDF]

Laryngoscope Investig Otolaryngol
Gao S, Jones J, Triantafillou V, Akst LM, Hillel AT, Motz KM, Klein AM, Best SR.   +7 more
europepmc   +1 more source

Cost-effectiveness of finotonlimab plus bevacizumab versus sorafenib as first-line therapy in unresectable hepatocellular carcinoma in China. [PDF]

Hum Vaccin Immunother
Xu H, Yu S, Yang Y, Bian H, Wu Z, Xuan F.   +5 more
europepmc   +1 more source

A Perspective on a Possible New Role for Bevacizumab Combined with Paclitaxel in Hormone-Resistant Metastatic Breast-Cancer Patients. [PDF]

J Clin Med
Allegrini G, Acconci G, Musettini G, Coltelli L, Finale C, Cupini S, Bartalini L, Orlandi P, Bocci G.   +8 more
europepmc   +1 more source

A Melanoma Transplanted in Nude Mice Has Both Host- and Tumor-Derived Blood Vessel- and Nerve-Like Structures. [PDF]

Cancer Sci
Obara K, Sasaki A, Hamada Y, Kubota Y, Aoki Y, Masaki N, Bouvet M, Amoh Y, Hoffman RM.   +8 more
europepmc   +1 more source

Deep Durable Response in Metastatic Hepatocellular Carcinoma After Early Discontinuation of Atezolizumab-Bevacizumab. [PDF]

ACG Case Rep J
O'Connor R, Coates D, Karunadasa H, Chan R, Spanger M, Nicoll A, Sawhney R.   +6 more
europepmc   +1 more source

Efficacy and safety of immune checkpoint inhibitors combined with chemotherapy versus bevacizumab combined with chemotherapy in first-line treatment of driver gene-negative advanced non-squamous non-small cell lung cancer: a single-center retrospective study. [PDF]

Front Oncol
Mo W, Li Y, Zhao L, Liu Y, Shu Q, Fei J.
europepmc   +1 more source

Adaptive dosing of immunotherapy plus anti-angiogenic therapy in a nonagenarian with hepatocellular carcinoma: a case report with 10-year survival. [PDF]

Front Oncol
Cui P, Sun G, Guo X, Yang J, Chang N, Huang H, Li N, Hu Y, Yin F, Zhang D.   +9 more
europepmc   +1 more source

Direct randomized evidence comparing ranibizumab and bevacizumab for macular edema secondary to retinal vein occlusion: a systematic review and meta-analysis. [PDF]

BMC Ophthalmol
Liang Y, Deng X, Chen M, Zhang X.
europepmc   +1 more source

Combining fruquintinib with TAS-102 as a promising strategy: antitumor activity in preclinical colorectal and gastric cancer xenograft models. [PDF]

BMC Cancer
Hara T, Morimoto M, Kakehi M, Kamedani M, Nakayama M, Yamamoto S, Osaka T, Soeda J, Bando H, Yoshino T.   +9 more
europepmc   +1 more source

The evolving role of immunotherapy in ovarian cancer. [PDF]

Cancer
Veneziani AC, Venegas L, Oza AM.
europepmc   +1 more source